Table 1.
White European (n = 638) | South Asian and African Caribbean† (n = 695) | ||
---|---|---|---|
Not on statins % depressed | 9.6 | 11.9 | |
On statins % depressed | 9.8 | 19.5* | |
Risk of depression according to statin use | Ethnic–statin interaction | ||
OR (95% CI) | P value | ||
Model 1: age and gender | 1.03 (0.60, 1.76) | 1.91 (1.22, 3.01)‡ | 0.11 |
Model 2: model 1 + manual labour and stressful life events | 0.96 (0.56, 1.65) | 1.89 (1.20, 2.99) | 0.087 |
Model 3: model 1 + smoking, alcohol intake and physical activity | 0.84 (0.47, 1.49) | 1.81 (1.14, 2.87) | 0.085 |
Model 4: model 1 + BMI, diabetes, hypertension and CVD | 0.58 (0.29, 1.15) | 1.66 (0.98, 2.83) | 0.036 |
Model 5: Full adjustment | 0.54 (0.26, 1.13) | 1.67 (0.97, 2.88) | 0.041 |
In sample with total cholesterol > 3mmol l–1§: | |||
Full adjustment | 0.52 (0.24, 1.13) | 1.60 (0.91, 2.79) | 0.049 |
Significant ethnic group difference of P < 0.05. BMI body mass index. CVD cardiovascular disease.
South Asians only: % depressed - not on statins = 10.2%, on statins = 17.9%*. For African-Caribbeans only: % depressed - not on statins = 14.6%, on statins = 24.8%*.
South Asians only: OR 1.94, 95% CI 1.07, 3.52, P = 0.13 for ethnic–statin interaction. African-Caribbeans only: OR 2.19, 95% CI 1.05, 4.57, P = 0.16 for ethnic–statin interaction.
To assess the potential confounding role of very low cholesterol, the sample was restricted to those participants with total cholesterol of >3mmol l–1.